ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Out of Focus

Out of Focus THE issue of drugs and pharmaceuticals, it would seem, is proving to be a major obstacle to the progress ofthe new economic regime. For over a year now the government has talked of a new drug policy and has attempted to tinker with it obviously with the intention of testing the waters, though it should be clear to even the most ardent supporters of the new economic measures that if the changes so enthusiastically adopted elsewhere are applied in toto to the drugs and pharmaceuticals industry, it will mean so sharp a rise in the prices of essential drugs as to deliver a death-blow to the ailing public health system. In addition, the long-term problems which will arise if the government were to accept the Dunkel proposals relating to patents for pharmaceutical products will need to be explained away. It is these political compulsions which have created some dissensions within the ruling party on the issue of the drug policy. Not surprisingly, therefore, the so-called new drug policy is being reviewed and re-reviewed for over six months now.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top